from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0908/ctpE

LFCtreatmentdescriptionclass of inhibitor

-0.750

Amikacinug/mL Amikacintranslation

-1.117

Cap5-10ug/mL Capreomycintranslation

-0.302

Rox10-50 ug/mL Roxithromycintranslation

-0.700

SM2-5 ug/mL Streptomycintranslation

-0.986

Tet5-10 ug/mL Tetracyclinetranslation

0.140

Rif0.2-5ug/mL Rifampicintranscription

1.192

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.883

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.359

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.100

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.486

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.094

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.183

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.497

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.632

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.127

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.907

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.227

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.788

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.021

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.159

KCN5-20 ug/mL Potassium cyaniderespiration

-0.466

NaN30.2-2 mM Sodium aziderespiration

0.065

Nigericin50 uM Nigericinrespiration

0.780

TRC10-150 ug/mL Triclosanrespiration

0.563

TRZ10-25 ug/mL Thioridazinerespiration

-1.014

Valinomycin0.5-10 uM Valinomycinrespiration

-2.264

ZnSO42 mM ZnSO4respiration

-0.150

menadione6-10 ug/mL Menadionerespiration

0.101

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.383

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.042

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.917

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.619

NRP_1Non-replicating persistence stage 1dosRassociated

-0.226

Amp0.2mg/mL AmpicillincellWall

0.251

Cephalexin20-100 ug/mL CephalexincellWall

0.203

Cerulenin0.32-5 ug/mL CerulenincellWall

-2.472

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-1.105

EMB10-20 ug/mL EthambutolcellWall

-0.426

Eta12-40 ug/mL EthionamidecellWall

-0.575

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.156

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.156

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.626

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.677

BZA0.12 mg/mL BenzamidearomaticAmides

0.412

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.408

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.914

H2O24 mM hydrogen peroxideDNAdamaging

0.215

Levo10 ug/mL LevofloxacinDNAdamaging

0.408

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.048

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.218

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.131

UVUV-irradiationDNAdamaging

1.158

ARP41-4 ug/mL Antitubercular compound ARP4?

0.081

Antimycin12.5-50 ug/mL Antimycin A?

-0.649

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.478

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.141

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.158

PA8240.2-2 ug/mL PA-824?

-0.246

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.183

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.052

Verapamil50 uM Verapamil?

0.425

mercaptoethanol2 mM 2-Mercaptoethanol?

0.069

methoxatin10-20 ug/mL Methoxatin?